Drupal.behaviors.print = function(context) {window.print();window.close();}>
FDA Clears SQI Diagnostics' Platform, Test for Celiac Disease
June 07, 2011
FDA Clears SQI Diagnostics' Platform, Test for Celiac Disease
The test is SQI's second multiplexed assay cleared by the FDA to run on the SQIDworks platform.
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
SQI Diagnostics May Seek Merger or Sale
November 19, 2012 / GenomeWeb Daily News
SQI, Integrated Sciences Partner on IVD Marketing Deal for Australia
February 14, 2012 / GenomeWeb Daily News
In Realignment, SQI to Streamline IVD Pipeline, Build Revenue from New CustomPlex Offering
December 6, 2011 / BioArray News
Docro to Help ArrayIt with FDA Process for OvaDx
March 22, 2010 / GenomeWeb Daily News
SQI's Q2 Revenues Drop to Zero
May 21, 2013 / GenomeWeb Daily News